(Q41701245)

7 October 2017

1 reference

title

The use of cytokine inhibitors. A new therapeutic insight into heart failure (English)

1 reference

7 October 2017

Matsumori A

1

1 reference

PubMed ID

9464576

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

International Journal of Cardiology

7 October 2017

1 reference

7 October 2017

62 Suppl 1

1 reference

7 October 2017

S3-12

1 reference

Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Expression and functional significance of tumor necrosis factor receptors in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Cytokines in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Elevated plasma interleukin-6 levels in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Cardiac release of cytokines and inflammatory responses in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interleukin-8 as a sensitive marker of unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Hypoxic stress induces cardiac myocyte-derived interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Effects of cytokines on the contractility of cultured cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

G protein-mediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Effects of interleukin 2 on cardiac function in the isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Persistent expression of cytokine in the chronic stage of viral myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Regulation of cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

What do the newer inotropic drugs have to offer?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Differential modulation of cytokine production by drugs: implications for therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Modulation of interleukin-1 beta production by cyclic AMP in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Prolonged elevation of intracellular cyclic AMP activates interleukin-1 production in human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Ion Channels and Signal Transduction in Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Interaction of cytotoxic T lymphocytes and guinea pig ventricular myocytes. Pharmacological modulation by blocking K+ currents in cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Increased nitric oxide production in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Nitric oxide synthase activities in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Vesnarinone inhibits induction of nitric oxide synthase in J774 macrophages and rat cardiac myocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Cyclic AMP is an essential factor in immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Verapamil ameliorates the clinical and pathological course of murine myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900206-4

7 January 2021

10.1016/S0167-5273(97)00206-4

Identifiers

DOI

1 reference

release_unggfk2jkzabjbd4bdqcol4t4e

7 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/unggfk2jkzabjbd4bdqcol4t4e

24 November 2022

mapped directly with Wikidata item

PubMed ID

9464576

1 reference

PubMed ID

9464576